Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income 0-355.91 K-147.01 K-207.28 K -710.2 K Non-Operating Income, Total 01.67 M1.72 M1.55 M 4.93 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 01.67 M1.72 M1.55 M 4.93 M Unusual income/expense ———— — Pretax income 01.31 M1.57 M1.34 M 4.22 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 01.31 M1.57 M1.34 M 4.22 M Discontinued operations ———— — Net income 01.31 M1.57 M1.34 M 4.22 M Dilution adjustment ———0 — Preferred dividends ———1.55 M — Diluted net income available to common stockholders 01.31 M1.57 M-207.28 K 2.68 M Basic earnings per share (Basic EPS) 00.070.090.07 0.23 Diluted earnings per share (Diluted EPS) 00.070.090.07 0.23 Average basic shares outstanding 5.07 M11.29 M14.44 M23.73 M — Diluted shares outstanding 5.07 M11.29 M14.44 M23.73 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —